Results of a 1-year quality-improvement process to reduce door-to-needle time in acute ischemic stroke with MRI screening
Affiliation auteurs | !!!! Error affiliation !!!! |
Titre | Results of a 1-year quality-improvement process to reduce door-to-needle time in acute ischemic stroke with MRI screening |
Type de publication | Journal Article |
Year of Publication | 2017 |
Auteurs | Sablot D., Gaillard N., Colas C., Smadja P., Gely C., Dutray A., Bonnec J.-M, Jurici S., Farouil G., Ferraro-Allou A., Jantac M., Allou T., Pujol C., Olivier N., Laverdure A., Fadat B., Mas J., Dumitrana A., Garcia Y., Touzani H., Perucho P., Moulin T., Richard C., Heroum C., Bouly S., Sagnes-Raffy C., Heve D. |
Journal | REVUE NEUROLOGIQUE |
Volume | 173 |
Pagination | 47-54 |
Date Published | JAN-FEB |
Type of Article | Article |
ISSN | 0035-3787 |
Mots-clés | Acute stroke therapy, Door-to-needle, Ischemic stroke, quality improvement, Reperfusion, Stroke, Stroke management, Stroke units, thrombectomy, thrombolysis, tPA |
Résumé | {Objective. - To determine the effects of a 1-year quality-improvement (QI) process to reduce door-to-needle (DTN) time in a secondary general hospital in which multimodal MRI screening is used before tissue plasminogen activator (tPA) administration in patients with acute ischemic stroke (AIS). Methods. - The QI process was initiated in January 2015. Patients who received intravenous (iv) tPA < 4.5 h after AIS onset between 26 February 2015 to 25 February 2016 (during implementation of the QI process; the ``2015 cohort'') were identified (n = 130), and their demographic and clinical characteristics and timing metrics compared with those of patients treated by iv tPA in 2014 (the ``2014 cohort'' |
DOI | 10.1016/j.neurol.2016.12.032 |